CYTK : Summary for Cytokinetics, Incorporated - Yahoo Finance

U.S. Markets close in 24 mins.

Cytokinetics, Incorporated (CYTK)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.85+0.65 (+6.37%)
As of 3:36PM EST. Market open.
People also watch
CORTGTXIARRYCYCCCRIS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close10.20
Open10.20
Bid10.70 x 1000
Ask10.75 x 7300
Day's Range10.20 - 10.88
52 Week Range6.00 - 13.45
Volume158,362
Avg. Volume302,700
Market Cap450.18M
Beta2.35
PE Ratio (TTM)27.82
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017
    Capital Cube4 days ago

    Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017

    Categories: Yahoo Finance Get free summary analysis Cytokinetics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Cytokinetics, Inc. – Acorda Therapeutics, Inc., Amgen Inc. and Array BioPharma Inc. (ACOR-US, AMGN-US and ARRY-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD ... Read more (Read more...)

  • ImmunoGen Posts Wider-than-Expected Loss; Sales Down Y/Y
    Zacks7 days ago

    ImmunoGen Posts Wider-than-Expected Loss; Sales Down Y/Y

    ImmunoGen, Inc. (IMGN) reported a loss of 39 cents per share (excluding restructuring charge) in the three month transition period ended Dec 31, marginally wider than both the Zacks Consensus Estimate and the year-ago loss of 38 cents.

  • TheStreet.com10 days ago

    Sage Therapeutics Leads Biotech Movers on False Takeout Rumors

    In addition to Sage Therapeutics, also moving biotech Friday: Novavax, Cytokinetics and Acadia Pharmaceuticals.